Skip to main content
Log in

Is Sentinel Lymph Node Biopsy Appropriate in Patients With Thin Melanomas: Too Early To Tell?

  • Editorial
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Morton DL, Thompson JF, Cochran AJ, Essner R, Elashoff R (2005) Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma. (ASCO abstract 7500). J Clin Oncol 23(16 Suppl):710

    Google Scholar 

  2. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. Lancet 351:793–6

    CAS  PubMed  Google Scholar 

  3. Carlson GW, Murray DR, Hestley A, et al (2003) Sentinel lymph node mapping for thick (>=4-mm) melanoma: should we be doing it? Ann Surg Oncol 10:408–15

    PubMed  Google Scholar 

  4. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF (2003) Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry, the Sydney Melanoma Unit. Cancer 98:1223–31

    Article  PubMed  Google Scholar 

  5. Wong SL, Brady MS, Busam KJ, Coit DG. Results of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol 2006; 13 (in press)

  6. Olah J, Gyulai R, Korom I, Varga E, Dobozy A (2003) Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas. Br J Dermatol 149:662–3

    Article  CAS  PubMed  Google Scholar 

  7. Kesmodel SB, Karakousis GC, Botbyl JD, et al (2005) Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 12:449–58

    Article  PubMed  Google Scholar 

  8. Koskivuo I, Suominen E, Niinikoski J, Talve L. Sentinel node metastasectomy in thin ≤1-mm melanoma. Langenbecks Arch Chir (in press)

  9. Karakousis GC, Gimotty PA, Kesmodel SB, et al (2005) Prognostic factors for nodal failure in patients with thin melanomas. Ann Surg Oncol 12(Suppl):S18–9

    Google Scholar 

  10. Sondak VK, Taylor JM, Sabel MS, et al (2004) Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 11:247–58

    Article  PubMed  Google Scholar 

  11. Agnese DM, Abdessalam SF, Burak WE Jr, Magro CM, Pozderac RV, Walker MJ (2003) Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 134:542–7; discussion 547–8

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John F. Thompson MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thompson, J.F., Shaw, H.M. Is Sentinel Lymph Node Biopsy Appropriate in Patients With Thin Melanomas: Too Early To Tell?. Ann Surg Oncol 13, 279–281 (2006). https://doi.org/10.1245/ASO.2006.08.927

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2006.08.927

Keywords

Navigation